GWRE vs JAZZ · P/E 524, rev $1.20B vs P/E 1988, rev $2.28B
Guidewire Software Inc (GWRE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Guidewire Software Inc (GWRE) is a software - application company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GWRE revenue for 2025-07-31 was $1.20B. Net income was $69.8M. GWRE currently screens at market cap $18.54B and trailing P/E 524.2.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GWRE currently screens at market cap $18.54B and trailing P/E 524.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GWRE and JAZZ stock pages for the full models.
Not investment advice.